Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. Ravina B, et al. Among authors: eberly s. Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690. Mov Disord. 2009. PMID: 19691116
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.
Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I. Ravina B, et al. Among authors: eberly s. Mov Disord. 2012 Sep 15;27(11):1392-7. doi: 10.1002/mds.25157. Epub 2012 Sep 13. Mov Disord. 2012. PMID: 22976926 Free PMC article.
Rasagiline improves quality of life in patients with early Parkinson's disease.
Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I; Parkinson Study Group. Biglan KM, et al. Among authors: eberly s. Mov Disord. 2006 May;21(5):616-23. doi: 10.1002/mds.20764. Mov Disord. 2006. PMID: 16450340 Clinical Trial.
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".
Schwarzschild MA, Marek K, Eberly S, Oakes D, Shoulson I, Jennings D, Seibyl J, Ascherio A; Parkinson Study Group PRECEPT Investigators. Schwarzschild MA, et al. Among authors: eberly s. Mov Disord. 2011 Aug 15;26(10):1864-8. doi: 10.1002/mds.23741. Epub 2011 Apr 29. Mov Disord. 2011. PMID: 21538532 Free PMC article.
Caffeine consumption and risk of dyskinesia in CALM-PD.
Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA; Parkinson Study Group. Wills AM, et al. Among authors: eberly s. Mov Disord. 2013 Mar;28(3):380-3. doi: 10.1002/mds.25319. Epub 2013 Jan 21. Mov Disord. 2013. PMID: 23339054 Free PMC article. Clinical Trial.
Reply: Unusual DAT scan results.
Ravina B, Marek K, Eberly S, Oakes D, Shoulson I. Ravina B, et al. Among authors: eberly s. Mov Disord. 2013 Jun;28(6):847. doi: 10.1002/mds.25447. Epub 2013 Apr 4. Mov Disord. 2013. PMID: 23559090 No abstract available.
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study.
Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D; Parkinson Study Group PRECEPT Investigators. Marek K, et al. Among authors: eberly s. Neurology. 2014 May 20;82(20):1791-7. doi: 10.1212/WNL.0000000000000424. Epub 2014 Apr 23. Neurology. 2014. PMID: 24759846 Free PMC article.
154 results